We highly recommend enabling Javascript while using the BlackBoxRX site.

Bictegravir/Emtricitabiine/Tenofovir Alafenamide

Post Treatment Acute Exacerbation of Hepatitis B

Severe Acute Exacerbations of hepatitis B

  • Severe acute exacerbations of hepatitis B have been reported in patients who are coinfected with HIV-1 and HBV and have discontinued products containing emtricitabine (FTC) and/or tenofovir disoproxil fumarate (TDF), and may occur with discontinuation of BIKTARVY. Closely monitor hepatic function in these patients. If appropriate, anti-hepatitis B therapy may be warranted.

Patient Counseling Information

Package Inserts

Bictegravir/Emtricitabine/Tenofovir Alafenamide

Updated March 2018